Drug intelligence / Profile preview

RU79256

Development stage: Unknown
Modality: Small Molecules

Overview

RU79256 is an experimental small molecule compound classified as a benzene and substituted derivative. Its chemical formula is C8H8O5S and it has a molecular weight of approximately 216.21 g/mol. The IUPAC name is (2R)-2-phenyl-2-sulfoacetic acid. RU79256 has been investigated as an inhibitor of the proto-oncogene tyrosine-protein kinase Src, which plays a key role in cell signaling pathways related to cancer and other diseases[1][2][4]. There are no approved indications or marketed uses for this compound; it remains at the experimental stage.

Other names: D-Sulfophenylacetic acid(2R)-2-phenyl-2-sulfoacetic acid1o4qSCHEMBL20869602SCHEMBL-20869602SCHEMBL 20869602

Targets

SRC (Proto-oncogene tyrosine-protein kinase Src)

Beyond the preview

Go deeper on RU79256.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RU79256.

Explore the full profile